CLICK4HP Archives

Health Promotion on the Internet

CLICK4HP@YORKU.CA
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
Treatment Uptake and Availability of Antimalarial Drugs for Intermittent Preventative Treatment in Pregnant Women in Malawi
From:
Anne Marie Hvid <[log in to unmask]>
Reply To:
Health Promotion on the Internet <[log in to unmask]>
Date:
Fri, 31 Jul 2015 10:27:01 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (31 lines) 
Throughout Africa, 30 million pregnant women are exposed to malaria
each year. Malaria in pregnancy carries increased risk of low
birthweight, severe maternal anemia, maternal mortality, miscarriage,
premature delivery, and stillbirth. To address malaria during
pregnancy, the Roll Back Malaria Consortium advocates a three-pronged
approach, one aspect of which is the delivery of intermittent
preventive treatment in pregnancy (IPTp) with
sulphadoxine-pyrimethamine (SP).

Treatment Uptake and Availability of Antimalarial Drugs for
Intermittent Preventative Treatment in Pregnant Women in Malawi, a new
report from the USAID | DELIVER PROJECT looks at Malawi to analyze the
relationship between SP stockout rates and coverage of SP for
intermittent preventative treatment of malaria in pregnant women. This
analysis was performed to explore the relationship between stock
availability and intervention coverage.

Download the publication at http://bit.ly/1SnWxJe

--

Anne Marie Hvid, PMP
Knowledge Management Advisor
USAID | DELIVER PROJECT
deliver.jsi.com

PHONE: 703.310.5256
WWW.JSI.COM

To manage subscriptions/passwords, or view archives, go to http://listserv.yorku.ca/archives/click4hp.html . [log in to unmask] is run in collaboration with Health Nexus: http://www.healthnexus.ca/index_eng.php

ATOM RSS1 RSS2